Clopidogrel tablet

DRUG5 trials

Sponsors

Kafrelsheikh University, Sarmad Zahoor, Peking Union Medical College Hospital

Conditions

Acute Coronary SyndromeBranch Atheromatous DiseaseIschemic Stroke

Phase 3

Ticagrelor Versus Clopidogrel in Ischemic Stroke

CompletedNCT05553613

Kafrelsheikh UniversityIschemic Stroke

Start: 2022-10-01End: 2024-01-01Updated: 2024-05-14

Efficacy and Safety of Tirofiban for Patients With BAD (BRANT)

CompletedNCT06037889

Peking Union Medical College HospitalBranch Atheromatous Disease

Start: 2023-11-09End: 2026-02-26Updated: 2026-03-03

Clopidogrel Versus Cilostazol in Ischemic Stroke

CompletedNCT06242132

Kafrelsheikh UniversityIschemic Stroke

Start: 2022-06-01End: 2024-08-01Updated: 2024-09-19

Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke

CompletedNCT06242145

Kafrelsheikh UniversityIschemic Stroke

Start: 2023-01-01End: 2024-08-01Updated: 2024-08-20

Phase 4

To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome

Sarmad ZahoorAcute Coronary Syndrome

Start: 2022-10-01End: 2023-07-31Target: 90Updated: 2022-10-10

Related Papers

Cilostazole versus clopidogrel in acute large-vessel moderate and moderate-to-severe ischemic stroke: a randomized controlled trial.

2025-04-151 citations

CILO-CLOP Trial: Cilostazol Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke: A Randomized Controlled Multicenter Trial

Neurology and Therapy2025-04-124 citations

TICA-CLOP STUDY: Ticagrelor Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke, a Randomized Controlled Multi-Center Trial

CNS Drugs2024-11-0910 citations

Efficacy and safety of tirofiban in patients with acute branch atheromatous disease-related stroke (BRANT): a protocol for a randomised controlled trial

BMJ Open2024-06-014 citations